What is the recommended dosing regimen of Valtrex (valacyclovir) for a patient with a cold sore?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Valtrex Dosing for Cold Sores

For cold sores (herpes labialis), the recommended dose of Valtrex is 2 grams twice daily for 1 day, with the two doses taken 12 hours apart, initiated at the earliest symptom such as tingling, itching, or burning. 1

Treatment Regimen Details

  • The FDA-approved dosing is specifically 2 grams taken twice in a single day (total of 4 grams over 24 hours), not extended beyond this 1-day period 1
  • Treatment must be initiated at the very first prodromal symptoms (tingling, itching, burning) before visible lesions develop for maximum effectiveness 1
  • The two doses should be spaced approximately 12 hours apart 1
  • Valtrex may be taken without regard to meals 1

Evidence Supporting This Regimen

  • Two large randomized, placebo-controlled trials demonstrated that this 1-day, high-dose regimen reduced the median duration of cold sore episodes by 1.0 day compared to placebo (P = 0.001) 2
  • The 1-day regimen prevented or blocked lesion development in an additional 6-8% of patients compared to placebo 2
  • Time to lesion healing and time to cessation of pain were both statistically significantly reduced with this valacyclovir regimen 2
  • This short-course, high-dose approach is supported by guideline recommendations recognizing that oral valacyclovir accelerates healing and decreases pain in recurrent herpes labialis 3

Critical Timing Considerations

  • There are no data on effectiveness of treatment initiated after visible cold sore lesions have already developed (papule, vesicle, or ulcer stage) 1
  • Patient-initiated therapy at the earliest prodromal symptoms may even prevent lesion development entirely 3
  • Patients should be provided with medication in advance so they can initiate treatment immediately when symptoms begin 1

Safety Profile

  • This regimen is generally well tolerated with minimal adverse events 3
  • Headache is the most common side effect, occurring slightly more frequently than placebo 3
  • Other mild adverse events include nausea, diarrhea, dyspepsia, dry mouth, and flatulence, but these occur at similar rates to placebo 3
  • Patients should maintain adequate hydration during treatment 1

Important Counseling Points

  • Valtrex is not a cure for cold sores 1
  • Treatment should not exceed 1 day (2 doses total) for cold sores 1
  • If a dose is missed, take it as soon as remembered, but do not double the next dose 1
  • Resistance to valacyclovir remains extremely rare (<0.5%) in immunocompetent patients despite over 20 years of widespread use 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.